Related Experiment Video
Updated: Dec 30, 2025

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
Urtica Dioica and Lamium Album Decrease Glycogen Synthase Kinase-3 beta and Increase K-Ras in Diabetic Rats
Mahmood Abedinzade1, Mohammad Rostampour2,3, Ebrahim Mirzajani2,4
1Medical Biotechnology Research Center, School of Paramedicine, Guilan University of Medical Sciences, Rasht, Iran.
Objectives:
The aim of the present work is evaluating the special effects of Urtica Dioica and Lamium Album on the serum level of K-Ras and GSK-3 beta in diabetic rats.
Methods:
In the present experimental study, 32 male Wistar rats randomly divided into 4 groups (Group I: normal control rats; receiving daily PBS, Group 2: diabetic control rats; receiving single dose of streptozotocin (60 mg/kg) and daily PBS, Group 3: Diabetic rats treated with 100 mg/kg of hydroalcoholic extract of the U. dioica, Group 4: Diabetic rats treated with 100 mg/kg of hydroalcoholic extract of L. Album. Diabetes-induced by an intraperitoneal injection of streptozotocin (60 mg/ kg). On the 14 th day of treatment, the weight, fasting blood sugar (FBS) and on 28 th day blood glucose, K-Ras and GSK3 beta was measured.
Results:
In diabetic group blood GSK-3 beta increase in comparison to control group (P < 0.05), also blood K-Ras decrease in the diabetic group (P < 0.05). Both extracts reduced GSK-3 beta level, however, this reduction was only statistically significant by U. dioica (P < 0.05). Compared to diabetic group, blood K-Ras level increased by both extract (P < 0.05). Also diabetes induction increase blood glucose levels and both extracts decrease its level significantly (P < 0.05). there is no significant differences among both extract effects on blood glucose, and K-Ras.
Conclusion:
For the first time shown that both extracts by regulating GSK-3 beta and K-Ras improve blood glucose level. More studies are needed to determine all the effects of these herbs.
Insights
This study investigated the effects of Urtica Dioica and Lamium Album extracts on diabetic rats. Both herbs helped regulate key proteins and improve blood glucose levels in diabetic models.
Area of Science:
- Biochemistry
- Pharmacology
- Diabetology
Background:
- Diabetes mellitus is a complex metabolic disorder characterized by hyperglycemia.
- Key signaling pathways involving K-Ras and GSK-3 beta play a role in glucose homeostasis.
- Natural compounds are being explored for their potential anti-diabetic effects.
Purpose of the Study:
- To evaluate the impact of Urtica Dioica and Lamium Album extracts on serum levels of K-Ras and GSK-3 beta in streptozotocin-induced diabetic rats.
- To assess the efficacy of these herbal extracts in modulating key molecular targets associated with diabetes.
Main Methods:
- A study involving 32 male Wistar rats, randomly assigned to control and diabetic groups.
- Diabetes was induced using streptozotocin (60 mg/kg).
- Treated groups received hydroalcoholic extracts of U. dioica or L. Album (100 mg/kg) daily for 28 days, with measurements of body weight, fasting blood sugar, blood glucose, K-Ras, and GSK-3 beta.
Main Results:
- Diabetic rats exhibited increased GSK-3 beta and decreased K-Ras levels compared to controls.
- Both U. dioica and L. Album extracts significantly reduced blood glucose levels.
- U. dioica extract significantly reduced GSK-3 beta levels, while both extracts increased K-Ras levels in diabetic rats.
- No significant differences were observed between the two extracts regarding their effects on blood glucose and K-Ras levels.
Conclusions:
- Urtica Dioica and Lamium Album extracts demonstrate potential in improving blood glucose levels in diabetic rats.
- These effects appear to be mediated through the regulation of GSK-3 beta and K-Ras pathways.
- Further research is warranted to fully elucidate the therapeutic potential and mechanisms of these herbs in diabetes management.
Related Concept Videos
Dipeptidyl Peptidase 4 Inhibitors
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Oral Hypoglycemic Agents: Biguanides and Glitazones

